WEST PHARMACEUTICAL SERVICES, INC. Operating Income
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Operating Income of $179.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for the quarter ending 2026-06-30 was $179.10M, a 16.53% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for the quarter ending 2026-03-31 was $177.10M, a 65.51% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for the quarter ending 2025-12-31 was $156.60M, a 1.88% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for the quarter ending 2025-09-30 was $167.60M, a 3.91% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for fiscal 2025 was $584.90M, a 2.63% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for fiscal 2024 was $569.90M, a 15.70% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for fiscal 2023 was $676.00M, a 7.90% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. operating income (loss) for fiscal 2022 was $734.00M, a 2.43% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $179.10M 10-Q · filed 2026-07-23 | $356.20M 10-Q · filed 2026-07-23 | $512.80M derived: sum of 3 quarters · filed 2026-07-23 | $680.40M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $177.10M 10-Q · filed 2026-04-23 | $333.70M derived: sum of 2 quarters · filed 2026-04-23 | $501.30M derived: sum of 3 quarters · filed 2026-04-23 | $655.00M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | $156.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $324.20M derived: sum of 2 quarters · filed 2026-02-17 | $477.90M derived: sum of 3 quarters · filed 2026-07-23 | $584.90M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $167.60M 10-Q · filed 2025-10-23 | $321.30M derived: sum of 2 quarters · filed 2026-07-23 | $428.30M 10-Q · filed 2025-10-23 | $587.90M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $153.70M 10-Q · filed 2026-07-23 | $260.70M 10-Q · filed 2026-07-23 | $420.30M derived: sum of 3 quarters · filed 2026-07-23 | $581.60M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $107.00M 10-Q · filed 2026-04-23 | $266.60M derived: sum of 2 quarters · filed 2026-04-23 | $427.90M derived: sum of 3 quarters · filed 2026-04-23 | $554.10M derived: sum of 4 quarters · filed 2026-04-23 | ||||
| 2024-12-31 | $159.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $320.90M derived: sum of 2 quarters · filed 2026-02-17 | $447.10M derived: sum of 3 quarters · filed 2026-02-17 | $569.90M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $161.30M 10-Q · filed 2025-10-23 | $287.50M derived: sum of 2 quarters · filed 2025-10-23 | $410.30M 10-Q · filed 2025-10-23 | $571.20M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $126.20M 10-Q · filed 2025-07-24 | $249.00M 10-Q · filed 2025-07-24 | $409.90M derived: sum of 3 quarters · filed 2026-02-17 | $587.20M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $122.80M 10-Q · filed 2025-04-24 | $283.70M derived: sum of 2 quarters · filed 2026-02-17 | $461.00M derived: sum of 3 quarters · filed 2026-02-17 | $643.50M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $160.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $338.20M derived: sum of 2 quarters · filed 2026-02-17 | $520.70M derived: sum of 3 quarters · filed 2026-02-17 | $676.00M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $177.30M 10-Q · filed 2024-10-24 | $359.80M derived: sum of 2 quarters · filed 2024-10-24 | $515.10M 10-Q · filed 2024-10-24 | $644.80M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $182.50M 10-Q · filed 2024-07-25 | $337.80M 10-Q · filed 2024-07-25 | $467.50M derived: sum of 3 quarters · filed 2025-02-18 | $653.70M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $155.30M 10-Q · filed 2024-04-25 | $285.00M derived: sum of 2 quarters · filed 2025-02-18 | $471.20M derived: sum of 3 quarters · filed 2025-02-18 | $699.60M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $129.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $315.90M derived: sum of 2 quarters · filed 2025-02-18 | $544.30M derived: sum of 3 quarters · filed 2025-02-18 | $734.00M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $186.20M 10-Q · filed 2023-10-26 | $414.60M derived: sum of 2 quarters · filed 2023-10-26 | $604.30M 10-Q · filed 2023-10-26 | $788.30M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $228.40M 10-Q · filed 2023-07-27 | $418.10M 10-Q · filed 2023-07-27 | $602.10M derived: sum of 3 quarters · filed 2024-02-20 | $783.50M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $189.70M 10-Q · filed 2023-04-27 | $373.70M derived: sum of 2 quarters · filed 2024-02-20 | $555.10M derived: sum of 3 quarters · filed 2024-02-20 | $766.40M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $184.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $365.40M derived: sum of 2 quarters · filed 2024-02-20 | $576.70M derived: sum of 3 quarters · filed 2024-02-20 | $752.30M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $181.40M 10-Q · filed 2022-10-27 | $392.70M derived: sum of 2 quarters · filed 2022-10-27 | $568.30M 10-Q · filed 2022-10-27 | $684.40M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $211.30M 10-Q · filed 2022-07-28 | $386.90M 10-Q · filed 2022-07-28 | $503.00M derived: sum of 3 quarters · filed 2023-02-21 | $602.20M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $175.60M 10-Q · filed 2022-04-28 | $291.70M derived: sum of 2 quarters · filed 2023-02-21 | $390.90M derived: sum of 3 quarters · filed 2023-02-21 | $494.50M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $116.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $215.30M derived: sum of 2 quarters · filed 2023-02-21 | $318.90M derived: sum of 3 quarters · filed 2023-02-21 | $406.90M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $99.20M 10-Q · filed 2021-10-28 | $202.80M derived: sum of 2 quarters · filed 2021-10-28 | $290.80M 10-Q · filed 2021-10-28 | $368.90M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $103.60M 10-Q · filed 2021-07-30 | $191.60M 10-Q · filed 2021-07-30 | $269.70M derived: sum of 3 quarters · filed 2022-02-22 | $337.00M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $88.00M 10-Q · filed 2021-04-30 | $166.10M derived: sum of 2 quarters · filed 2022-02-22 | $233.40M derived: sum of 3 quarters · filed 2022-02-22 | $313.90M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | $78.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $145.40M derived: sum of 2 quarters · filed 2022-02-22 | $225.90M derived: sum of 3 quarters · filed 2022-02-22 | $296.60M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $67.30M 10-Q · filed 2020-10-23 | $147.80M derived: sum of 2 quarters · filed 2020-10-23 | $218.50M 10-Q · filed 2020-10-23 | $284.30M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $80.50M 10-Q · filed 2020-07-24 | $151.20M 10-Q · filed 2020-07-24 | $217.00M derived: sum of 3 quarters · filed 2021-02-23 | $277.80M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $70.70M 10-Q · filed 2020-04-24 | $136.50M derived: sum of 2 quarters · filed 2021-02-23 | $197.30M derived: sum of 3 quarters · filed 2021-02-23 | $257.60M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $65.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $126.60M derived: sum of 2 quarters · filed 2021-02-23 | $186.90M derived: sum of 3 quarters · filed 2021-02-23 | $240.30M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $60.80M 10-Q · filed 2019-10-29 | $121.10M derived: sum of 2 quarters · filed 2019-10-29 | $174.50M 10-Q · filed 2019-10-29 | $234.90M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $60.30M 10-Q · filed 2019-07-29 | $113.70M 10-Q · filed 2019-07-29 | $174.10M derived: sum of 3 quarters · filed 2020-02-24 | $237.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $53.40M 10-Q · filed 2019-05-08 | $113.80M derived: sum of 2 quarters · filed 2020-02-24 | $176.70M derived: sum of 3 quarters · filed 2020-02-24 | $218.70M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $60.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $123.30M derived: sum of 2 quarters · filed 2020-02-24 | $165.30M derived: sum of 3 quarters · filed 2020-02-24 | $225.80M 10-K · filed 2020-02-24 | $228.90M 10-K · filed 2018-02-26 | |||
| 2017-09-30 | $62.90M 10-Q · filed 2018-10-30 | $63.90M 10-Q · filed 2017-10-31 | $104.90M derived: sum of 2 quarters · filed 2018-10-30 | $165.40M 10-Q · filed 2018-10-30 | $167.90M 10-Q · filed 2017-10-31 | $218.10M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $42.00M 10-Q · filed 2018-07-31 | $42.70M 10-Q · filed 2017-08-01 | $102.50M 10-Q · filed 2018-07-31 | $104.00M 10-Q · filed 2017-08-01 | $155.20M derived: sum of 3 quarters · filed 2019-02-28 | $206.50M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $60.50M 10-Q · filed 2018-05-08 | $61.30M 10-Q · filed 2017-05-05 | $113.20M derived: sum of 2 quarters · filed 2019-02-28 | $164.50M derived: sum of 3 quarters · filed 2019-02-28 | $225.70M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $52.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $104.00M derived: sum of 2 quarters · filed 2019-02-28 | $165.20M derived: sum of 3 quarters · filed 2019-02-28 | $195.20M 10-K · filed 2019-02-28 | $196.80M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $51.30M 10-Q · filed 2017-10-31 | $112.50M derived: sum of 2 quarters · filed 2017-10-31 | $142.50M 10-Q · filed 2017-10-31 | $187.70M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $61.20M 10-Q · filed 2017-08-01 | $91.20M 10-Q · filed 2017-08-01 | $136.40M derived: sum of 3 quarters · filed 2018-02-26 | $132.90M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $30.00M 10-Q · filed 2017-05-05 | $75.20M derived: sum of 2 quarters · filed 2018-02-26 | $71.70M derived: sum of 3 quarters · filed 2018-02-26 | $110.80M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $45.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $41.70M derived: sum of 2 quarters · filed 2018-02-26 | $80.80M derived: sum of 3 quarters · filed 2018-02-26 | $128.60M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | -$3.50M 10-Q · filed 2016-10-31 | $35.60M derived: sum of 2 quarters · filed 2016-10-31 | $83.40M 10-Q · filed 2016-10-31 | $128.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $39.10M 10-Q · filed 2016-08-01 | $86.90M 10-Q · filed 2016-08-01 | $131.50M derived: sum of 3 quarters · filed 2017-02-28 | $175.50M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $47.80M 10-Q · filed 2016-05-06 | $92.40M derived: sum of 2 quarters · filed 2017-02-28 | $136.40M derived: sum of 3 quarters · filed 2017-02-28 | $190.50M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $88.60M derived: sum of 2 quarters · filed 2017-02-28 | $142.70M derived: sum of 3 quarters · filed 2017-02-28 | $182.00M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $44.00M 10-Q · filed 2015-11-02 | $98.10M derived: sum of 2 quarters · filed 2015-11-02 | $137.40M 10-Q · filed 2015-11-02 | $174.30M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $54.10M 10-Q · filed 2015-08-03 | $93.40M 10-Q · filed 2015-08-03 | $130.30M derived: sum of 3 quarters · filed 2016-02-26 | $170.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $39.30M 10-Q · filed 2015-05-06 | $76.20M derived: sum of 2 quarters · filed 2016-02-26 | $115.90M derived: sum of 3 quarters · filed 2016-02-26 | $158.40M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $36.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $76.60M derived: sum of 2 quarters · filed 2016-02-26 | $119.10M derived: sum of 3 quarters · filed 2016-02-26 | $162.40M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $39.70M 10-Q · filed 2014-11-03 | $82.20M derived: sum of 2 quarters · filed 2014-11-03 | $125.50M 10-Q · filed 2014-11-03 | $157.00M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $42.50M 10-Q · filed 2014-08-01 | $85.90M 10-Q · filed 2014-08-01 | $117.30M derived: sum of 3 quarters · filed 2015-02-25 | $143.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $43.30M 10-Q · filed 2014-05-08 | $74.80M derived: sum of 2 quarters · filed 2015-02-25 | $101.10M derived: sum of 3 quarters · filed 2015-02-25 | $136.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $31.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $57.80M derived: sum of 2 quarters · filed 2015-02-25 | $93.40M derived: sum of 3 quarters · filed 2015-02-25 | $135.10M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | $26.30M 10-Q · filed 2013-11-04 | $61.90M derived: sum of 2 quarters · filed 2013-11-04 | $103.60M 10-Q · filed 2013-11-04 | $130.60M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $35.60M 10-Q · filed 2013-08-05 | $77.30M 10-Q · filed 2013-08-05 | $104.30M derived: sum of 3 quarters · filed 2014-02-27 | $130.40M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $41.70M 10-Q · filed 2013-05-06 | $68.70M derived: sum of 2 quarters · filed 2014-02-27 | $94.80M derived: sum of 3 quarters · filed 2014-02-27 | $122.60M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $53.10M derived: sum of 2 quarters · filed 2014-02-27 | $80.90M derived: sum of 3 quarters · filed 2014-02-27 | $109.60M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $26.10M 10-Q · filed 2012-11-05 | $53.90M derived: sum of 2 quarters · filed 2012-11-05 | $82.60M 10-Q · filed 2012-11-05 | $88.60M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $27.80M 10-Q · filed 2012-08-06 | $56.50M 10-Q · filed 2012-08-06 | $62.50M derived: sum of 3 quarters · filed 2013-02-27 | $87.80M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $28.80M 10-Q · filed 2012-05-04 | $34.70M derived: sum of 2 quarters · filed 2013-02-27 | $60.00M derived: sum of 3 quarters · filed 2013-02-27 | $90.50M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $31.20M derived: sum of 2 quarters · filed 2013-02-27 | $61.70M derived: sum of 3 quarters · filed 2013-02-27 | $90.70M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $25.30M 10-Q · filed 2011-11-07 | $55.80M derived: sum of 2 quarters · filed 2011-11-07 | $84.80M 10-Q · filed 2011-11-07 | $106.40M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-06-30 | $30.50M 10-Q/A · filed 2011-08-08 | $59.40M 10-Q/A · filed 2011-08-08 | $81.10M derived: sum of 3 quarters · filed 2012-03-01 | $107.00M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-03-31 | $28.90M 10-Q · filed 2011-05-05 | $50.60M derived: sum of 2 quarters · filed 2012-03-01 | $76.50M derived: sum of 3 quarters · filed 2012-03-01 | $105.20M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2009-12-31 | $21.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $47.60M derived: sum of 2 quarters · filed 2012-03-01 | $76.30M derived: sum of 3 quarters · filed 2012-03-01 | $97.50M 10-K/A · filed 2012-03-01 | ||||
| 2009-09-30 | $25.90M 10-Q · filed 2010-11-05 | $54.60M derived: sum of 2 quarters · filed 2010-11-05 | $75.80M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $28.70M 10-Q · filed 2010-08-05 | $49.90M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $124.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |